BPH Global Ltd (ASX:BP8)
Australia · Delayed Price · Currency is AUD 0.0020
0.00 (0.00%)
At close: Jul 23, 2025, 4:00 PM AEST
BPH Global Revenue
BPH Global had revenue of 50.94K AUD in the half year ending December 31, 2024, with 14,925.37% growth. This brings the company's revenue in the last twelve months to 160.90K. In the fiscal year ending June 30, 2024, BPH Global had annual revenue of 109.97K with 32,338.05% growth.
Revenue (ttm)
160.90K
Revenue Growth
+32,338.05%
P/S Ratio
13.06
Revenue / Employee
5.19K
Employees
31
Market Cap
2.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 109.97K | 109.63K | 32,338.05% |
| Jun 30, 2023 | 339.00 | -493.67K | -99.93% |
| Jun 30, 2022 | 494.01K | -8.00M | -94.19% |
| Jun 30, 2021 | 8.50M | 7.77M | 1,063.19% |
| Jun 30, 2020 | 730.36K | -831.07K | -53.23% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |